2,6-DIFLUORO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ANILINE, 95.0%, 1g

(2S,3R)-2-Methyl-3-((methylsulfonyl)methyl)azetidine hydrochloride, 98%, 5g

5-Chloro-2-methylpyrazolo[1,5-a]pyrimidine, 95.0%, 10g

1-Bromo-4-propylbenzene, 98.0%, 25g

4-(3-Methoxy-4-nitrophenyl)morpholine, 1g

1-(4-Methoxyphenyl)-2-methylpropan-1-ol, 95.0%, 5g

4-Nitrobenzophenone, 95.0%, 500g

5-bromo-2-methyl-2H-isoindole-1-sulfonic acid, 97.0%, 500mg

2,4-Difluorobenzenesulfonyl chloride, 98.0%, 500g

2-(4-Trifluoromethyl-5,6,7,8-tetrahydro-quinazolin-2-yl)-ethylamine hydrochloride, 95.0%, 500mg

1-((3-(trifluoromethyl)phenyl)sulfonamido)cyclohexane-1-carboxylic acid, 95.0%, 250mg

Impföse steril, 10 µl, 3,9 mm, 100 x 10 1000 Stück

Trimethylbromosilane, 97%, 5g